Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LB2102 |
Synonyms | |
Therapy Description |
LB2102 comprises autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting DLL3, which potentially induce toxicity in DLL3-expressing tumor cells (NCI Drug Dictionary). |